Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Expands By 10.9%

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 8,110,000 shares, a growth of 10.9% from the August 15th total of 7,310,000 shares. Based on an average daily trading volume, of 1,050,000 shares, the days-to-cover ratio is presently 7.7 days. Approximately 19.1% of the shares of the company are sold short.

Insider Activity at ASP Isotopes

In related news, major shareholder Ak Jensen Investment Managemen bought 61,849 shares of the business’s stock in a transaction that occurred on Wednesday, July 10th. The stock was purchased at an average cost of $3.40 per share, for a total transaction of $210,286.60. Following the purchase, the insider now directly owns 6,678,723 shares in the company, valued at $22,707,658.20. The purchase was disclosed in a filing with the SEC, which is available through this link. 26.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Fielder Capital Group LLC acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $55,000. Rhumbline Advisers bought a new stake in ASP Isotopes in the second quarter valued at approximately $116,000. Rathbones Group PLC bought a new stake in ASP Isotopes in the 4th quarter valued at $272,000. HTLF Bank raised its position in shares of ASP Isotopes by 197.0% in the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after purchasing an additional 70,000 shares during the period. Finally, Virtu Financial LLC lifted its position in ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after acquiring an additional 69,176 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Price Performance

Shares of NASDAQ ASPI traded down $0.01 during mid-day trading on Wednesday, hitting $2.64. 180,203 shares of the stock were exchanged, compared to its average volume of 800,274. The company has a market cap of $136.65 million, a P/E ratio of -5.00 and a beta of 5.11. The company has a debt-to-equity ratio of 2.06, a quick ratio of 4.00 and a current ratio of 4.00. ASP Isotopes has a twelve month low of $0.84 and a twelve month high of $5.67. The stock’s fifty day simple moving average is $2.56 and its two-hundred day simple moving average is $3.41.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million for the quarter. As a group, analysts forecast that ASP Isotopes will post -0.24 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, HC Wainwright dropped their price target on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.